| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000032889 |
| Receipt No. | R000037502 |
| Official scientific title of the study | Study of the clinical outcome of Goreisan in patients with abnormal fluid retention. |
| Date of disclosure of the study information | 2018/06/06 |
| Last modified on | 2018/10/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Study of the clinical outcome of Goreisan in patients with abnormal fluid retention. | |
| Title of the study (Brief title) | Study of the clinical outcome of Goreisan in patients with abnormal fluid retention. | |
| Region |
|
|
| Condition | |||
| Condition | Abnormal fluid retention | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To examine the efficacy of Goreisan in patients with abnormal fluid retention. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | A total of 3days urine volume form the day after participation in this study. |
| Key secondary outcomes | Serum creatinine, electrolyte, liver enzyme, body weight, and the degree of peripheral edema. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Additional administration of Goreisan 7.5g/day on intravenous injection of diuretics for abnormal fluid retention. | |
| Interventions/Control_2 | Intravenous injection of diuretics for abnormal fluid retention. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Patients who need intravenous injection of diuretics due to abnormal fluid retention.
2) Patients who gave written informed consent |
|||
| Key exclusion criteria | 1) Patients younger than 20 years old
2) Patients who have allergy for cinnamon 3) Patients who are pregnant or hope to be pregnant 4) Patients who cannot take oral administration 5) Patients who have no urination due to end-stage renal failure on hemodialysis 6) Patients who are not expected to react to diuretics due to acute kidney injury 7) Patients who participate in another interventional trial 8) Patients whose doctor in charge do not agree to join the trial |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Masami Sakurada |
| Organization | Tokorozawa Heart Center |
| Division name | Department of Cardiology |
| Address | 2-61-11 Kamiarai, Tokorozawa, Saitama, JAPAN 359-1142 |
| TEL | 04-2940-8611 |
| hirotakaezaki@gmail.com | |
| Public contact | |
| Name of contact person | Hirotaka Ezaki |
| Organization | Tokorozawa Heart Center |
| Division name | Department of Cardiology |
| Address | 2-61-11 Kamiarai, Tokorozawa, Saitama, JAPAN 359-1142 |
| TEL | 04-2940-8611 |
| Homepage URL | |
| hirotakaezaki@gmail.com | |
| Sponsor | |
| Institute | Tokorozawa Heart Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tokorozawa Heart Center |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 所沢ハートセンター(埼玉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037502 |